Brief: Specialty Pharmaceutical Company Endo Launches Ibuprofen-Famotidine Tablets
26/03/2024 13:02
March 26 (Reuters) - Endo International PLC ENDPQ.PK :
* ENDO LAUNCHES IBUPROFEN-FAMOTIDINE TABLETS, GENERIC
VERSION OF
DUEXIS®
Source text for Eikon: ID:nPreVFhkVa
Further company coverage: ENDPQ.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes